JP2008526893A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2008526893A5 JP2008526893A5 JP2007550575A JP2007550575A JP2008526893A5 JP 2008526893 A5 JP2008526893 A5 JP 2008526893A5 JP 2007550575 A JP2007550575 A JP 2007550575A JP 2007550575 A JP2007550575 A JP 2007550575A JP 2008526893 A5 JP2008526893 A5 JP 2008526893A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- inhalable
- inhalable pharmaceutical
- patient
- insulin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US64305405P | 2005-01-10 | 2005-01-10 | |
| PCT/US2006/000910 WO2006086107A2 (en) | 2005-01-10 | 2006-01-10 | Methods and compositions for minimizing accrual of inhalable insulin in the lungs |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2008526893A JP2008526893A (ja) | 2008-07-24 |
| JP2008526893A5 true JP2008526893A5 (enExample) | 2009-03-05 |
Family
ID=36793549
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2007550575A Withdrawn JP2008526893A (ja) | 2005-01-10 | 2006-01-10 | 肺における吸入可能なインスリンの自然増加を最少化するための方法及び組成物 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20060153778A1 (enExample) |
| EP (1) | EP1858486A2 (enExample) |
| JP (1) | JP2008526893A (enExample) |
| AU (1) | AU2006213084A1 (enExample) |
| CA (1) | CA2592776A1 (enExample) |
| MX (1) | MX2007008379A (enExample) |
| WO (1) | WO2006086107A2 (enExample) |
Families Citing this family (36)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2280004B1 (en) | 1999-06-29 | 2016-04-20 | MannKind Corporation | Pharmaceutical formulations comprising insulin complexed with a diketopiperazine |
| US9006175B2 (en) | 1999-06-29 | 2015-04-14 | Mannkind Corporation | Potentiation of glucose elimination |
| EP1494732B1 (en) | 2002-03-20 | 2008-01-30 | MannKind Corporation | Inhalation apparatus |
| US20070027063A1 (en) * | 2004-01-12 | 2007-02-01 | Mannkind Corporation | Method of preserving the function of insulin-producing cells |
| DK1786784T3 (da) | 2004-08-20 | 2011-02-14 | Mannkind Corp | Katalyse af diketopiperazinsyntese |
| CN104436170B (zh) | 2004-08-23 | 2018-02-23 | 曼金德公司 | 用于药物输送的二酮哌嗪盐 |
| AU2014271222B2 (en) * | 2005-09-14 | 2016-04-28 | Mannkind Corporation | Method of drug formulation based on increasing the affinity of crystalline microparticle surfaces for active agents |
| AU2006290227B2 (en) | 2005-09-14 | 2012-08-02 | Mannkind Corporation | Method of drug formulation based on increasing the affinity of crystalline microparticle surfaces for active agents |
| KR20080096809A (ko) | 2006-02-22 | 2008-11-03 | 맨카인드 코포레이션 | 디케토피페라진 및 활성제를 포함하는 마이크로입자의 약학특성의 개선 방법 |
| US8785396B2 (en) | 2007-10-24 | 2014-07-22 | Mannkind Corporation | Method and composition for treating migraines |
| KR101736502B1 (ko) * | 2007-10-24 | 2017-05-16 | 맨카인드 코포레이션 | Ｇｌｐ-1에 의한 유해 효과의 예방 방법 |
| SG10201507036TA (en) | 2008-06-13 | 2015-10-29 | Mannkind Corp | A dry powder inhaler and system for drug delivery |
| US20190262557A1 (en) * | 2010-03-04 | 2019-08-29 | Mannkind Corporation | Dry powder drug delivery system |
| US8485180B2 (en) * | 2008-06-13 | 2013-07-16 | Mannkind Corporation | Dry powder drug delivery system |
| EP2609954B1 (en) | 2008-06-20 | 2021-12-29 | MannKind Corporation | An interactive apparatus for real-time profiling of inhalation efforts |
| US11110151B2 (en) * | 2008-08-11 | 2021-09-07 | Mannkind Corporation | Composition and method for reducing hypoglycemia events in diabetes treatment |
| TWI614024B (zh) * | 2008-08-11 | 2018-02-11 | 曼凱公司 | 超快起作用胰島素之用途 |
| US8314106B2 (en) | 2008-12-29 | 2012-11-20 | Mannkind Corporation | Substituted diketopiperazine analogs for use as drug delivery agents |
| MX2011007371A (es) * | 2009-01-08 | 2011-09-06 | Mannkind Corp | Metodo para tratar la hiperglucemia con la molecula. |
| MX2011009251A (es) * | 2009-03-04 | 2011-11-18 | Mannkind Corp | Sistema mejorado de suministro de farmaco en polvo seco. |
| AU2014200960B2 (en) * | 2009-03-04 | 2016-02-11 | Mannkind Corporation | An improved dry powder drug delivery system |
| MX2011009512A (es) | 2009-03-11 | 2011-11-29 | Mannkind Corp | Aparato, sistema y metodo para medir la resistencia de un inhalador. |
| MY157166A (en) | 2009-06-12 | 2016-05-13 | Mankind Corp | Diketopiperazine microparticles with defined specific surface areas |
| MY172858A (en) * | 2009-06-12 | 2019-12-12 | Mannkind Corp | Diketopiperazine microparticles with defined isomer contents |
| CA2778698A1 (en) | 2009-11-03 | 2011-05-12 | Mannkind Corporation | An apparatus and method for simulating inhalation efforts |
| IL223742A (en) | 2010-06-21 | 2016-06-30 | Mannkind Corp | A dry powder inhaler and preparation for it |
| EP2694402B1 (en) | 2011-04-01 | 2017-03-22 | MannKind Corporation | Blister package for pharmaceutical cartridges |
| WO2012174472A1 (en) | 2011-06-17 | 2012-12-20 | Mannkind Corporation | High capacity diketopiperazine microparticles |
| HK1200318A1 (en) | 2011-10-24 | 2015-08-07 | 曼金德公司 | Methods and compositions for treating pain |
| EP2872205B1 (en) | 2012-07-12 | 2017-02-08 | MannKind Corporation | Dry powder drug delivery systems |
| US10159644B2 (en) | 2012-10-26 | 2018-12-25 | Mannkind Corporation | Inhalable vaccine compositions and methods |
| WO2014144895A1 (en) | 2013-03-15 | 2014-09-18 | Mannkind Corporation | Microcrystalline diketopiperazine compositions and methods |
| KR102465025B1 (ko) | 2013-07-18 | 2022-11-09 | 맨카인드 코포레이션 | 열-안정성 건조 분말 약제학적 조성물 및 방법 |
| EP3030294B1 (en) | 2013-08-05 | 2020-10-07 | MannKind Corporation | Insufflation apparatus |
| US10307464B2 (en) | 2014-03-28 | 2019-06-04 | Mannkind Corporation | Use of ultrarapid acting insulin |
| US10561806B2 (en) | 2014-10-02 | 2020-02-18 | Mannkind Corporation | Mouthpiece cover for an inhaler |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2000301A (en) * | 1932-04-02 | 1935-05-07 | Norman Confections Inc | Progressive container |
| US5352461A (en) * | 1992-03-11 | 1994-10-04 | Pharmaceutical Discovery Corporation | Self assembling diketopiperazine drug delivery system |
| US5888477A (en) * | 1993-01-29 | 1999-03-30 | Aradigm Corporation | Use of monomeric insulin as a means for improving the bioavailability of inhaled insulin |
| US5547929A (en) * | 1994-09-12 | 1996-08-20 | Eli Lilly And Company | Insulin analog formulations |
| US6428771B1 (en) * | 1995-05-15 | 2002-08-06 | Pharmaceutical Discovery Corporation | Method for drug delivery to the pulmonary system |
| EP2280004B1 (en) * | 1999-06-29 | 2016-04-20 | MannKind Corporation | Pharmaceutical formulations comprising insulin complexed with a diketopiperazine |
| AU2005204378B2 (en) * | 2004-01-12 | 2009-01-22 | Mannkind Corporation | A method of reducing serum proinsulin levels in type 2 diabetics |
-
2006
- 2006-01-10 CA CA002592776A patent/CA2592776A1/en not_active Abandoned
- 2006-01-10 JP JP2007550575A patent/JP2008526893A/ja not_active Withdrawn
- 2006-01-10 MX MX2007008379A patent/MX2007008379A/es unknown
- 2006-01-10 US US11/330,427 patent/US20060153778A1/en not_active Abandoned
- 2006-01-10 WO PCT/US2006/000910 patent/WO2006086107A2/en not_active Ceased
- 2006-01-10 EP EP06748159A patent/EP1858486A2/en not_active Withdrawn
- 2006-01-10 AU AU2006213084A patent/AU2006213084A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Nishimura | High-flow nasal cannula oxygen therapy in adults: physiological benefits, indication, clinical benefits, and adverse effects | |
| Shankar et al. | Isoflurane therapy for severe refractory status asthmaticus in children | |
| Diaz et al. | Delivery and safety of inhaled interferon-γ in idiopathic pulmonary fibrosis | |
| JP2015110631A5 (enExample) | ||
| JP2011500850A5 (enExample) | ||
| Defresne et al. | Recruitment of lung volume during surgery neither affects the postoperative spirometry nor the risk of hypoxaemia after laparoscopic gastric bypass in morbidly obese patients: a randomized controlled study | |
| Morán et al. | Heat and moisture exchangers and heated humidifiers in acute lung injury/acute respiratory distress syndrome patients. Effects on respiratory mechanics and gas exchange | |
| YU36302A (sh) | Novi tiotropiumski preparati - koji sadrže prah za inhaliranje | |
| AR067639A1 (es) | Medicamentos pulverulentos que contienen tiotropio y salmetrol, asi como lactosa como excipiente | |
| WO2006059108A3 (en) | ANTI-IL-IRl SINGLE DOMAIN ANTIBODIES AND THERAPEUTIC USES | |
| MXPA03011861A (es) | Particulas para inhalacion que tienen rapidas propiedades de liberacion. | |
| UA101652C2 (uk) | Композиція для інгаляції, що містить аклідиній для лікування астми та хронічного обструктивного захворювання легень | |
| JP2007520507A5 (enExample) | ||
| Eden et al. | Prolonged smoldering Douglas fir smoke inhalation augments respiratory resistances, stiffens the aorta, and curbs ejection fraction in hypercholesterolemic mice | |
| JP2023523557A5 (enExample) | ||
| Brain | Unlocking the opportunity of tight glycaemic control: Inhaled insulin: safety | |
| CN102133319B (zh) | 一种平喘止咳的药物及其制备方法 | |
| WO2005041922A3 (en) | Composition | |
| Berkowitz et al. | Laryngeal foreign bodies in children revisited | |
| ATE339951T1 (de) | Pulverzubereitungen zur inhalation | |
| Araújo et al. | Transitory increased blood pressure after upper airway surgery for snoring and sleep apnea correlates with the apnea-hypopnea respiratory disturbance index | |
| Chattopadhyay et al. | Respiratory response to tobacco dust exposure among biddi binders: A follow up and bronchodilator study | |
| JP2017524732A5 (enExample) | ||
| Hall | Wearing a noseclip improves nebulised aerosol delivery | |
| Ahsan et al. | A case report on aspiration pneumonia of a Jamunapari buck |